Tag Archives: REMS

New FDA Guidances – February 2011

Posted on 8 March 2011 by Ask-Cato.com Contributor

Each month, Cato Research Regulatory Scientist Cathy Anderson compiles a list of the notable guidance documents released by the FDA.  Here’s a summary of the guidances released in February 2011 (links go directly to PDF documents). Clinical Pharmacogenomics: Premarketing Evaluation … Continue reading →

Posted in Clinical Trials, FDA, Industry News, Regulatory Strategy | Tagged , , , , , , , | Comments Off

Joint Statistical Meetings 2010 Retrospective: A CRO Statistician’s Perspective

Posted on 16 August 2010 by Ask-Cato.com Contributor

Image via Wikipedia The Joint Statistical Meetings is often a good place to learn about emerging issues in the analysis of clinical trials (and all of the other fields that statistics touches, as a matter of fact). Here are just a … Continue reading →

Posted in Conferences and Meetings, Statistics | Tagged , , , , , , , , , , | 1 Comment

Free Webinar – Past, Present and Future of REMS: Can We Mitigate With Restraint?

Posted on 22 June 2010 by Evan Richardson

Join Cato Research for a free educational webinar on Thursday, 24 June 2010 at 2:00 PM ET.  The webinar, titled Past, Present and Future of REMS: Can We Mitigate With Restraint?, will be presented by Jack Snyder, M.D., J.D., Ph.D., … Continue reading →

Posted in Webinars | Tagged , , | 1 Comment